Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2002. Start Trial.
Date Value
September 30, 2026 98.34%
August 31, 2026 98.34%
July 31, 2026 98.34%
June 30, 2026 98.34%
May 31, 2026 98.34%
April 30, 2026 98.34%
March 31, 2026 98.34%
February 28, 2026 98.34%
January 31, 2026 98.34%
December 31, 2025 98.34%
November 30, 2025 98.34%
October 31, 2025 98.34%
September 30, 2025 98.34%
August 31, 2025 98.34%
July 31, 2025 98.34%
June 30, 2025 98.34%
May 31, 2025 98.34%
April 30, 2025 98.34%
March 31, 2025 98.34%
February 28, 2025 98.34%
January 31, 2025 98.34%
December 31, 2024 98.34%
November 30, 2024 98.28%
October 31, 2024 98.28%
September 30, 2024 98.28%
Date Value
August 31, 2024 98.28%
July 31, 2024 97.94%
June 30, 2024 97.38%
May 31, 2024 96.67%
April 30, 2024 96.67%
March 31, 2024 95.56%
February 29, 2024 95.56%
January 31, 2024 95.56%
December 31, 2023 95.56%
November 30, 2023 95.56%
October 31, 2023 95.56%
September 30, 2023 94.88%
August 31, 2023 93.19%
July 31, 2023 93.00%
June 30, 2023 93.00%
May 31, 2023 93.00%
April 30, 2023 92.25%
March 31, 2023 88.38%
February 28, 2023 83.69%
January 31, 2023 83.69%
December 31, 2022 83.69%
November 30, 2022 83.69%
October 31, 2022 83.69%
September 30, 2022 83.69%
August 31, 2022 83.69%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Univec, Inc. 99.00%
Lantheus Holdings, Inc. 59.46%
Zomedica Corp. 98.88%
IDEXX Laboratories, Inc. 54.00%
Neogen Corp. 90.92%